Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL122808 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1396195 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL735586 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1076271 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL156385 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1804580 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL734680 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL736397 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL2020039 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL14760076 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3341409-B1 | BIOPHARMACEUTICAL COMPOSITIONS | GLAXOSMITHKLINE IP NO 2 LTD (GB) | 2026-02-25 | — | — | EP | claimed |
| EP-3347043-B1 | PROCESS FOR PREPARING AN ATTENUATED TETRAVALENT DENGUE VACCINE | FUND BUTANTAN (BR) | 2026-01-07 | — | — | EP | claimed |
| US-20250242115-A1 | DISPENSING DEVICE AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITIS | GLENMARK SPECIALTY S.A. (CH) | 2025-07-31 | — | — | US | claimed |
| US-12303635-B2 | Dispensing device and pharmaceutical composition for the treatment of rhinitis | GLENMARK SPECIALTY S.A. (CH) | 2025-05-20 | — | — | US | claimed |
| CN-119264879-A | Inorganic salt phase change material and preparation method and application thereof | 广东美的暖通设备有限公司 | 2025-01-07 | — | — | CN | claimed |
| EP-3419651-B1 | IMPROVED NAGLU FUSION PROTEIN FORMULATION | BIOMARIN PHARM INC (US) | 2023-10-25 | — | — | EP | claimed |
| EP-3294345-B1 | TPP1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE | BIOMARIN PHARM INC (US) | 2023-10-18 | — | — | EP | claimed |
| US-20230285689-A1 | DISPENSING DEVICE AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITIS | GLENMARK SPECIALTY S.A. (CH) | 2023-09-14 | — | — | US | claimed |
| CN-111787954-B | Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine | 格兰马克专业公司 | 2023-09-05 | — | — | CN | claimed |
| CN-107072121-B | Quick soaking energy storage heat radiation structure for eliminating heat wave crest | 平湖阿莱德实业有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-20130245124-A1 | PRESERVATIVE FREE BIMATOPROST SOLUTIONS | ALLERGAN, INC. (US) | 2013-09-19 | — | — | US | claimed |
| EP-2598117-A2 | PRESERVATIVE FREE BIMATOPROST SOLUTIONS | Allergan, Inc. (US) | 2013-06-05 | — | — | EP | claimed |
| US-20120213700-A1 | COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN | NAVIDEA BIOPHARMACEUTICALS, INC. (US) | 2012-08-23 | — | — | US | claimed |
| WO-2012015996-A2 | PRESERVATIVE FREE BIMATOPROST SOLUTIONS | ALLERGAN, INC. (US) | 2012-02-02 | — | — | WO | claimed |
| EP-1712245-B1 | Calcium phosphate cement | HOWMEDICA OSTEONICS CORP (US) | 2012-02-01 | — | — | EP | claimed |
| US-20100196272-A1 | COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN | NEOPROBE CORPORATION (US) | 2010-08-05 | — | — | US | claimed |
| WO-2010087959-A1 | COMPOSITIONS FOR RADIOLABELING DIETHYLENETRIAMINEPENTAACETIC ACID (DTPA)-DEXTRAN | NEOPROBE CORPORATION (US) | 2010-08-05 | — | — | WO | claimed |
| US-20090131537-A1 | Wound healing compositions | WILLE JR JOHN JACOB | 2009-05-21 | — | — | US | claimed |
| WO-2006029463-A1 | HEAT EXCHANGER IMPROVEMENTS | INFORM ENERGY PTY LTD (AU) | 2006-03-23 | — | — | WO | claimed |
| EP-0799046-B1 | STABLE SOLUTIONS OF 2-CHLORO-2'-DEOXYADENOSINE | ORTHO PHARMA CORP (US) | 2002-06-05 | — | — | EP | claimed |